Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SYK | P43405 | 14/20 | 0.46 |
| ▸ | EGFR | P00533 | 6/20 | 0.41 |
| ▸ | BTK | Q06187 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL655795 | 0.87 | MAPT (0.39) | — | |
| SCHEMBL655873 | 0.83 | SYK (0.61) | SYKEGFR | |
| SCHEMBL655302 | 0.78 | SYK (0.68) | SYKEGFR | |
| SCHEMBL655289 | 0.69 | SYK (0.69) | SYKEGFR | |
| SCHEMBL656378 | 0.69 | SYK (0.67) | SYK | |
| SCHEMBL655791 | 0.69 | SYK (0.67) | SYK | |
| SCHEMBL655299 | 0.68 | SYK (0.67) | SYKEGFR | |
| SCHEMBL655167 | 0.68 | SYK (0.78) | SYKEGFR | |
| SCHEMBL655775 | 0.68 | SYK (0.78) | SYKEGFR | |
| SCHEMBL6016741 | 0.68 | SYK (0.62) | SYKEGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040029902-A1 | Antiinflamamtory agents | MIDCAP FINANCIAL TRUST | 2004-02-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040029902-A1 | Antiinflamamtory agents | FCER2, FCGR1A, HNMT | SYK 251/4885EGFR 1288/4885BTK 596/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.